As demand for advanced therapies continues to surge, the biopharma industry is under pressure to innovate faster in high-risk areas like drug discovery and cell therapy. These fields face persistent challenges, such as high costs, long development timelines, and complex regulatory landscapes. To that end, MaxCyte has introduced a new high-throughput electroporation platform that streamlines...
Antibody-drug conjugates (ADCs) present unique analytical challenges, particularly in maintaining consistent drug-to-antibody ratio (DAR), minimizing variability, and reducing reliance on time-intensive off-line methods. These challenges are further compounded by the need to limit handling of highly potent payloads while maintaining process control. This webinar explores how variable pathlength spectroscopy enables rapid, accurate at-line and in-line...
Join Us for the BVS and BioMed Realty Biotech Community Event! Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. The vendor fair is held at The Forum, in the same building as Amgen and next to Genentech, right in...
Connect with innovators, investors, and companies advancing cancer breakthroughs, in person or virtually, during Chicago’s biggest oncology event through the BIO Partnering™ system.
Join this thought leadership panel exploring how the CAR-T landscape continues to evolve as clinical and commercial experience grows. As autologous therapies expand into additional settings and allogeneic approaches continue to be studied, organizations are reassessing where to focus research, development, and operational efforts. This discussion brings together perspectives from across the cell therapy ecosystem...
By invitation only. You must be pre-registered by your Jefferies representative in order to attend. The Jefferies Global Healthcare Conference in New York will take place on Tuesday, June 2 – Thursday June 4, 2026. This year’s conference will focus on life sciences companies in the biotechnology, life sciences tools and services, medical technology, and...
What You'll Learn: How does life sciences continue to be Boston’s and Cambridge's economic engine amid a softening market? With total VC investment at $6.85B across 197 rounds in 2025, is capital concentrating into fewer winners, and how is that changing tenant decision making? Where are AI enabled life sciences users, automation heavy labs, and data...
We are very excited to announce our outdoor Biotech Community Event at SOVA Science District. This is a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. Our last events were a HUGE success with 300 high-quality people registering from over 100+ companies/institutes & we...
Reimagine what's possible—together. Join BSI Consulting for an expert-led forum designed for pharma and biotech professionals who are shaping the next era of EHS. Connect with peers, challenge assumptions, and explore practical solutions to the industry's most pressing risks and opportunities. This event brings together leaders at the forefront of life sciences in EHS to...
The webinar also highlights the growing role of AI within regulated manufacturing environments. Rather than treating AI as an add-on, the session outlines how to embed it into validated frameworks to support predictive maintenance, yield optimization, and faster product release cycles.
This webinar series explores two powerful, complementary disciplines that CDMOs leverage to tackle these challenges head-on. First, we examine the solid-state domain, exploring how targeted crystallization development can directly address purification, filtration, stability, and processability challenges from lab scale through commercialization. Then, we see how chromatographic modeling tools in combination with innovative techniques like “fraction...
Bringing innovative antibody therapeutics to market quickly requires more than upstream efficiency. It demands adaptable and robust downstream purification strategies. As novel mAb formats increase in complexity, purification challenges grow. Achieving required purity and yield often extends beyond traditional 2–3 step platform processes, requiring expanded chromatography options and optimized buffer systems. In this webinar, we...
